Actavis.

PositionCHARLOTTE

LINCOLNTON -- Actavis, a Reykjavik, Iceland-based generic-drug maker, plans to move part of its liquid-drug manufacturing from Baltimore to its factory here, where it employs about 200. The $22 million expansion will...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT